<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01384695</url>
  </required_header>
  <id_info>
    <org_study_id>GCO# 09-0696 Project 1</org_study_id>
    <nct_id>NCT01384695</nct_id>
  </id_info>
  <brief_title>A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1</brief_title>
  <official_title>A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia - Project 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anandasabapathy, Sharmila, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Anandasabapathy, Sharmila, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to obtain data to evaluate whether high-resolution
      imaging of the gastrointestinal mucosain vivo can assist clinicians in detecting dysplastic
      (precancerous) areas. This is an exploratory study of a confocal endoscope designed to
      evaluate the feasibility of using this FDA-approved device in the endoscopic surveillance of
      subjects at high-risk for neoplasia in the upper and lower GI tract. The confocal endoscope
      provides real-time in vivo microscopic images of the mucosa which resemble standard
      pathology.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low/no enrollment. No subjects were enrolled over the past year.
  </why_stopped>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>to determine whether tissue is neoplastic or non-neoplastic</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>GERD</condition>
  <condition>Barrett's Esophagus</condition>
  <arm_group>
    <arm_group_label>Fluorescein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Confocal imaging using contrast agent fluorescein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Proflavine hemisulfate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>confocal imaging using contrast agent proflavine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluorescein</intervention_name>
    <description>fluorescent contrast agent, Fluorescein 5ml</description>
    <arm_group_label>Proflavine hemisulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Proflavine hemisulfate</intervention_name>
    <description>3 ml of 0.01% proflavine (derived from dissolving 10mg proflavine hemisulfate USP in 100ml sterile water)</description>
    <arm_group_label>Fluorescein</arm_group_label>
    <other_name>Proflavine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient 18 years or older

          -  colonoscopy for screening or surveillance of polyps or disease of colon

          -  anoscopy because of suspected or known anal dysplasia or neoplasia

        Exclusion Criteria:

          -  patient unable to provide informed consent

          -  patient found unfit for standard colonoscopy or anoscopy with biopsies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharmila Anandasabapathy, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mt. Sinai School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2011</study_first_submitted>
  <study_first_submitted_qc>June 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2011</study_first_posted>
  <last_update_submitted>January 8, 2016</last_update_submitted>
  <last_update_submitted_qc>January 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Barrett's esophagus</keyword>
  <keyword>confocal microendoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Barrett Esophagus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Proflavine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

